基本信息
浏览量:151
职业迁徙
个人简介
Clinical Trial Unit Studienpraxis Urologie, Nürtingen, Germany; Medical School, Eberhard-Karls University, Tuebingen, Germany
Tilman Todenhöfer is a urologist with a focus on the management of advanced genitourinary malignancies including prostate and bladder cancer. He has obtained his MD at the university of Freibug Germany. He has been trained as resident at the Eberhard-Karls-University Tuebingen (Chair: Prof. A. Stenzl). Under the supervision of Peter Black and Kim Chi, he worked as postdoctoral research fellow at the Vancouver Prostate Centre, Vancouver, Canada. From 2017 to 2019 he was faculty member at the Dept. of Urology and the lead of the clinical trial unit of the department. In 2019, he was appointed associate Professor of Urology at the Eberhard-Karls-University Tuebingen (apl. Professor). In 2019 he has joined the clinical trial unit "Studienpraxis Urologie“ as principal investigator and co-head of the clinical trial unit.
Tilman Todenhöfer has published over 130 peer reviewed publications. He is a member of various national and international urological associations and research networks and reviewer of various journals including Lancet European Urology, the Journal of Urology, Lancet Oncology Urologic Oncology, Nature Reviews Urology, International Journal of Urology, BMC cancer. He is member of the editorial board of Disease Markers. His major research interests are biomarkers in advanced bladder and prostate cancer, circulating biomarker and bone metastases. He has been awarded numerous prestigious awards including the Maximlian Nitze Award, the Alken Award, the Research award of the Canadian Urologic Association (CUA) and the John Blandy Prize of the British Association of Urological Surgeons.
Tilman Todenhöfer is a urologist with a focus on the management of advanced genitourinary malignancies including prostate and bladder cancer. He has obtained his MD at the university of Freibug Germany. He has been trained as resident at the Eberhard-Karls-University Tuebingen (Chair: Prof. A. Stenzl). Under the supervision of Peter Black and Kim Chi, he worked as postdoctoral research fellow at the Vancouver Prostate Centre, Vancouver, Canada. From 2017 to 2019 he was faculty member at the Dept. of Urology and the lead of the clinical trial unit of the department. In 2019, he was appointed associate Professor of Urology at the Eberhard-Karls-University Tuebingen (apl. Professor). In 2019 he has joined the clinical trial unit "Studienpraxis Urologie“ as principal investigator and co-head of the clinical trial unit.
Tilman Todenhöfer has published over 130 peer reviewed publications. He is a member of various national and international urological associations and research networks and reviewer of various journals including Lancet European Urology, the Journal of Urology, Lancet Oncology Urologic Oncology, Nature Reviews Urology, International Journal of Urology, BMC cancer. He is member of the editorial board of Disease Markers. His major research interests are biomarkers in advanced bladder and prostate cancer, circulating biomarker and bone metastases. He has been awarded numerous prestigious awards including the Maximlian Nitze Award, the Alken Award, the Research award of the Canadian Urologic Association (CUA) and the John Blandy Prize of the British Association of Urological Surgeons.
研究兴趣
论文共 276 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Marko Vukovic, Jorge M Chamlati,Jörg Hennenlotter,Tilman Todenhöfer, Thomas Lütfrenk, Sebastian Jersinovic,Igor Tsaur,Arnulf Stenzl,Steffen Rausch
International journal of molecular sciencesno. 4 (2024)
Marko Vukevic, Jorge M Chamlati,Jörg Hennenlotter,Tilman Todenhöfer, Thomas Lütfrenk, Sebastian Jersinovic,Igor Tsaur,Arnulf Stenzl, Steffen Rausch¹
crossref(2024)
Marko Vukovic, Jorge M. Chamlati,Jörg Hennenlotter,Tilman Todenhöfer, Thomas Lütfrenk, Sebastian Jersinovic,Igor Tsaur,Arnulf Stenzl,Steffen Rausch
International Journal of Molecular Sciencesno. 4 (2024): 2447
Nature Reviews Urologyno. 10 (2023): 597-614
引用3浏览0引用
3
0
UROLOGIEno. 12 (2023): 1289-1294
Methods in molecular biology (Clifton, N.J.) (2023): 199-212
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn